UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.69 +0.67 (+0.86%) GOLD FUTURES
2,392.60 +32.70 (+1.39%) DOW
39,830.69 +272.58 (+0.69%) Bitcoin GBP
51,566.87 +3,192.33 (+6.60%)
ADC Therapeutics SA (ADCT)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:23PM EDT. Market open.
| Previous close | 4.0400 |
| Open | 4.1200 |
| Bid | 4.1200 x 900 |
| Ask | 4.1300 x 1000 |
| Day's range | 4.0628 - 4.3200 |
| 52-week range | 0.3600 - 6.0400 |
| Volume | |
| Avg. volume | 599,401 |
| Market cap | 410.016M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations
ADC Therapeutics ( NYSE:ADCT ) First Quarter 2024 Results Key Financial Results Revenue: US$18.1m (down 4.9% from 1Q...
- GuruFocus.com
Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)
On May 7, 2024, Ameet Mallik, Chief Executive Officer of ADC Therapeutics SA (NYSE:ADCT), sold 29,731 shares of the company.
- Simply Wall St.
ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Last week, you might have seen that ADC Therapeutics SA ( NYSE:ADCT ) released its quarterly result to the market. The...
© 2024 Yahoo. All rights reserved.